SAN FRANCISCO--(BUSINESS WIRE)--Fluxion Biosciences, a leading developer of microfluidic systems for cellular analysis in life sciences research and drug discovery, today announced that it has signed a distribution agreement with AutoMate Scientific. The distribution agreement covers Fluxion’s BioFlux™ platform for studying cellular interactions. Fluxion’s BioFlux system offers researchers a powerful analysis tool for the study of biofilms and cellular adhesion.
